Consistent with literature, we report sex-differences in the age-associated development of myocardial hypertrophy and deterioration of cardiac function; however, we demonstrate novel data highlighting the beneficial effect of deleting sEH. The gene discussed is EPHX2; the disease is cardiac hypertrophy.